Security key
02157Q109
Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO)
CUSIP: 02157Q109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 31,755,000
- Total 13F shares
- 17,296,212
- Share change
- -3,632,917
- Total reported value
- $38,050,471
- Price per share
- $2.20
- Number of holders
- 78
- Value change
- -$7,942,231
- Number of buys
- 39
- Number of sells
- 45
Report period
Q2 2025
Institutions
78
Top holders
10
ANRO full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Alto Neuroscience, Inc. SEC filings
Alto Neuroscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02157Q109
Recent filing periods:
Top shareholders of ANRO - Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alpha Wave Global, LP |
13F
3/4/5
|
Company · 10%+ Owner |
12%
|
3,707,757
|
$8,008,755 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
5%
|
1,600,000
|
$3,456,000 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
2.1%
from 13D/G
|
1,459,176
|
$3,151,820 | — | 31 Mar 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
4.7%
|
1,265,546
|
$2,885,445 | $0 | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.9%
|
1,240,053
|
$2,678,514 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
1,218,645
|
$2,632,273 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.7%
|
1,162,608
|
$2,511,233 | — | 31 Mar 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
2.9%
|
915,000
|
$1,976,400 | — | 31 Mar 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
2.8%
|
901,984
|
$1,948,285 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.7%
|
852,990
|
$1,842,457 | — | 31 Mar 2025 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
2.1%
|
667,778
|
$1,442,400 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.9%
|
589,279
|
$1,272,842 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.6%
|
510,210
|
$1,102,053 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
500,589
|
$1,081,272 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
486,859
|
$1,051,920 | — | 31 Mar 2025 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
477,101
|
$1,030,538 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.3%
|
400,000
|
$864,000 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.1%
|
359,873
|
$777,326 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
338,716
|
$731,627 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.79%
|
250,000
|
$540,000 | — | 31 Mar 2025 | |
| Almitas Capital LLC |
13F
|
Company |
0.74%
|
234,386
|
$506,274 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.55%
|
175,000
|
$378,001 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.47%
|
150,421
|
$324,909 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.44%
|
139,953
|
$302,298 | — | 31 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.41%
|
130,141
|
$281,105 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.32%
|
100,374
|
$216,808 | — | 31 Mar 2025 | |
| SCS Capital Management LLC |
13F
|
Company |
0.21%
|
66,777
|
$144,238 | — | 31 Mar 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.21%
|
65,189
|
$140,808 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
56,132
|
$121,245 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.17%
|
53,929
|
$117,000 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
49,545
|
$107,017 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
46,807
|
$101,104 | — | 31 Mar 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.13%
|
40,199
|
$86,830 | — | 31 Mar 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.13%
|
40,000
|
$86,400 | — | 31 Mar 2025 | |
| CITIZENS FINANCIAL GROUP INC/RI |
13F
|
Company |
0.12%
|
38,606
|
$83,389 | — | 31 Mar 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.12%
|
37,000
|
$79,920 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.1%
|
31,031
|
$67,027 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
29,100
|
$62,856 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.09%
|
28,002
|
$60,484 | — | 31 Mar 2025 | |
| RBF Capital, LLC |
13F
|
Company |
0.09%
|
27,359
|
$59,095 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
27,127
|
$58,586 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
26,142
|
$56,467 | — | 31 Mar 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.08%
|
25,000
|
$54,000 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.08%
|
24,099
|
$52,054 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
22,508
|
$48,617 | — | 31 Mar 2025 | |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO |
13F
|
Company |
0.07%
|
22,175
|
$47,898 | — | 31 Mar 2025 | |
| Bowie Capital Management, LLC |
13F
|
Company |
0.06%
|
19,484
|
$42,085 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
16,564
|
$35,778 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
16,179
|
$34,947 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.05%
|
15,269
|
$32,982 | — | 31 Mar 2025 |
Institutional Holders of Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO) as of Q2 2025
As of 30 Jun 2025,
Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,296,212 shares.
The largest 10 holders included
Alpha Wave Global, LP, ARMISTICE CAPITAL, LLC, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Vestal Point Capital, LP, MARSHALL WACE, LLP, 72 Investment Holdings, LLC, BlackRock, Inc., and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
83
Q2 2025 holders
78
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.